Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy

Tumor microenvironment is extremely immunosuppressive, preventing efficient induction of antitumor immunity. To overcome tumor-mediated immunosuppression and enhance the potency of immunogene therapy, oncolytic adenovirus (Ad) co-expressing interleukin (IL)-12 and vascular endothelial growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hyo Min, Hong, JinWoo, Yun, Chae-Ok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356712/
https://www.ncbi.nlm.nih.gov/pubmed/27821803
http://dx.doi.org/10.18632/oncotarget.13087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356712/
https://www.ncbi.nlm.nih.gov/pubmed/27821803
http://dx.doi.org/10.18632/oncotarget.13087

Ejemplares similares